Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis

被引:10
作者
Gupta, S. [1 ]
Sodhani, P. [1 ]
Sharma, A. [2 ]
Sharma, J. K. [2 ]
Halder, K. [1 ]
Charchra, K. L. [1 ]
Sardana, S. [3 ]
Singh, V. [4 ]
Sehgal, A. [3 ]
Das, B. C. [5 ]
机构
[1] Inst Cytol & Prevent Oncol ICMR, Div Cytopathol, Noida 201301, India
[2] Inst Cytol & Prevent Oncol ICMR, Div Mol Genet, Noida 201301, India
[3] Inst Cytol & Prevent Oncol ICMR, Div Epidemiol & Biostat, Noida 201301, India
[4] Inst Cytol & Prevent Oncol ICMR, Div Clin Oncol, Noida 201301, India
[5] Inst Cytol & Prevent Oncol ICMR, Div Mol Oncol, Noida 201301, India
关键词
high-risk; human papillomavirus; cervical cancer screening; cytology; epidemiology; risk factors; CERVICAL-CANCER; HPV INFECTION; DNA-SEQUENCES; INDIAN WOMEN; AGE; EPIDEMIOLOGY; DETERMINANTS; TERMINOLOGY; TESTS;
D O I
10.1111/j.1365-2303.2008.00611.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: To determine the prevalence of high-risk human papillomavirus (HR-HPV) 16/18 infection of uterine cervix among women in the reproductive age group, with cytologically normal cervical (Pap) smears; to analyse the risk factors for HR-HPV acquisition and to address their implications for cervical cancer screening and prophylaxis in a low resource setting. Methods: Cervical samples from 769 cytologically negative women (age 18-45 years) attending a tertiary care centre in Delhi were subjected to HPV DNA testing and HR-HPV 16/18 and low-risk (LR)-HPV 6/11 sub-typing by polymerase chain reaction. Univariate risk factor analysis was carried out in HR-HPV positive (n = 86) versus HR-HPV negative women (n = 683) by chi-square test. Results: The overall HPV prevalence among cytologically normal women was 16.6%. HR-HPV16 was detected in 10.1%, whereas HPV18 was detected in 1% of women. HR-HPV 16/18 comprised 67% of the total HPV positives. There was no decline in HR-HPV positivity with age, and women aged 40-44 years were at significantly increased risk for HR-HPV prevalence (P = 0.03). Statistically significant associations of HR-HPV infection were found with risk factors such as high parity (P = 0.04), cervicitis/hypertrophic cervix (P = 0.01), unhealthy cervix (P = 0.04), rural residence (P = 0.03), low socioeconomic status (P = 0.01) and illiteracy (P = 0.07). Conclusions: Although the sample size was small, based on the observation that HR-HPV 16 and 18 contributed significantly to the overall HPV prevalence in our setting, we speculate that testing/prophylaxis for these prevalent high-risk types could perhaps make cervical cancer screening and preventive programmes cost-effective. Larger community-based studies on HPV prevalence and persistence are required to validate these findings before definitive recommendations can be made to the policy makers.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 39 条
[1]  
Aggarwal R, 2006, Indian J Cancer, V43, P110
[2]   Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear [J].
Arora, R ;
Kumar, A ;
Prusty, BK ;
Kailash, U ;
Batra, S ;
Das, BC .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 121 (01) :104-109
[3]   The epidemiology of human papillomavirus infection and its association with cervical cancer [J].
Bosch, F. Xavier ;
Qiao, You-Lin ;
Castellsague, Xavier .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 94 :S8-S21
[4]   Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women [J].
Bulkmans, NWJ ;
Rozendaal, L ;
Snijders, PJF ;
Voorhorst, FJ ;
Boeke, AJP ;
Zandwijken, GRJ ;
van Kemenade, FJ ;
Verheijen, RHM ;
von Groningen, K ;
Boon, ME ;
Keuning, HJF ;
van Ballegooijen, M ;
van den Brule, AJC ;
Meijer, CJLM .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (01) :94-101
[5]   Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples [J].
Cibas, Edmund S. ;
Hong, Xuefei ;
Crum, Christopher P. ;
Feldman, Sarah .
GYNECOLOGIC ONCOLOGY, 2007, 104 (03) :702-706
[6]   Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis [J].
Clifford, GM ;
Gallus, S ;
Herrero, R ;
Muñoz, N ;
Snijders, PJF ;
Vaccarella, S ;
Anh, PTH ;
Ferreccio, C ;
Hieu, NT ;
Matos, E ;
Molano, M ;
Rajkumar, R ;
Ronco, G ;
de Sanjosé, S ;
Shin, HR ;
Sukvirach, S ;
Thomas, JO ;
Tunsakul, S ;
Meijer, CJLM ;
Franceschi, S .
LANCET, 2005, 366 (9490) :991-998
[7]  
DAS BC, 1989, LANCET, V2, P1271
[8]   A HIGH-FREQUENCY OF HUMAN PAPILLOMAVIRUS DNA-SEQUENCES IN CERVICAL CARCINOMAS OF INDIAN WOMEN AS REVEALED BY SOUTHERN BLOT HYBRIDIZATION AND POLYMERASE CHAIN-REACTION [J].
DAS, BC ;
SHARMA, JK ;
GOPALKRISHNA, V ;
DAS, DK ;
SINGH, V ;
GISSMANN, L ;
HAUSEN, HZ ;
LUTHRA, UK .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (04) :239-245
[9]  
DAS BC, 1993, CANCER, V72, P147, DOI 10.1002/1097-0142(19930701)72:1<147::AID-CNCR2820720128>3.0.CO
[10]  
2-7